Comparison between permeability coefficients in rat and human jejunum

Pharmaceutical Research

Volumn 13, Issue 9, 1996, Pages 1336-1342

  Fagerholm, Urban ^a   Johansson, Monica ^b   Lennernäs, Hans ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

bioavailability; in situ in vivo correlation; intestinal perfusion; intestinal permeability; oral absorption

Indexed keywords

ATENOLOL; FUROSEMIDE; GLUCOSE; KETOPROFEN; LEVODOPA; MACROGOL 4000; METOPROLOL; NAPROXEN; PHENAZONE; TERBUTALINE;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; DRUG ABSORPTION; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; INTESTINE PERFUSION; JEJUNUM; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPYRINE; GLUCOSE; HUMANS; INTESTINAL ABSORPTION; JEJUNUM; MALE; MODELS, BIOLOGICAL; PERFUSION; PERMEABILITY; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029855969     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016065715308     Document Type: Article

References (35)

1. U. Fagerholm and H. Lennernäs. Experimental estimation of the effective unstirred water layer thickness in the human jejunum, and its importance in oral drug absorption. Eur. J. Pharm. Sci., 3:247-53 (1995).
2. A. Walter and J. Gutknecht. Permeability of small nonelectrolytes through lipid bilayer membranes. J. Membrane Biol., 90:207-17 (1986).
3. J. S. Trier and J. L. Madara. Chapter 35: Functional morphology of the mucosa of the small intestine. In Physiology of the gastrointestinal tract (2nd edition). Ed. L. R. Johnson. Raven Press, New York, 1981, pp. 925-61.
4. D. C. Taylor, J. Lynch, and D. E. Leahy. Chapter II: Models for intestinal permeability to drugs. In Drug delivery to the gastrointestinal tract, Ed. J. G. Hardy, S. S. Davis and C. G. Wilson. Chichester, U. K. Ellis Horwood Ltd., 1989, pp. 133-45.
5. H. Lennernäs, Ö Ahrenstedt, and A-L. Ungell. Intestinal drug absorption during induced net water absorption in man: A mechanistic study using antipyrine, atenolol and enalaprilat. Br. J. Clin. Pharmacol., 37:589-96 (1994).
6. D. Nilsson, U. Fagerholm, and H. Lennernäs. The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum. Pharm. Res., 11:1541-5 (1994).
7. U. Fagerholm, L. Borgström, Ö Ahrenstedt, and H. Lennernäs. The lack of effect of induced net fluid absorption on the in vivo permeability of terbutaline in the human jejunum. J. Drug Targeting, 3:191-200 (1995).
8. H. Lennernäs. Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation? Pharm. Res., 12:1573-82 (1995).
9. M. R. Uhing and R. E. Kimura. Active transport of 3-O-methylglucose by the small intestine in chronically catheterized rats. J. Clin. Invest., 95:2799-805 (1995).
10. J. M. Diamond. News and views: How to be physiological. Nature, 376:117-8 (1995).
11. H. Lennernäs, Ö Ahrenstedt, R. Hällgren, L. Knutson, M. Ryde, and L. Paalzow Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm. Res., 9:1243-51 (1992).
12. H. Lennernäs, D. Nilsson, S-M. Aquilonius, Ö. Ahrenstedt, L. Knutson, and L. Paalzow. The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man. Br. J. Clin. Pharmacol., 35:243-50 (1993).
13. H. Lennernäs, L. Knutson, T. Knutson, L. Lesko, T. Salomonson, and G. L. Amidon. Human effective permeability data for atenolol, metoprolol and carbamazepine to be used in the proposed biopharmaceutical classification for IR-products. Pharm. Res., 12:295 (1995).
14. H. Lennernäs, L. Knutson, T. Knutson, L. Lesko, T. Salomonson, and G. L. Amidon. Human effective permeability data for furosemide, hydrochlortiazide, ketoprofen and naproxen to be used in the proposed biopharmaceutical classification for IR-products. Pharm. Res., 12:396 (1995).
15. G. L. Amidon, P. J. Sinko, and D. Fleisher. Estimating human oral fraction dose absorbed: A correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res., 5:651-4 (1988).
16. R. Schultz and D. Winne. Relationship between antipyrine absorption and blood flow rate in rat jejunum, ileum and colon. Naunyn-Schm. Arch Pharmacol, 335:97-102 (1987).
17. I-D. Lee, U. Fagerholm, H. Lennernäs, and G. Amidon. A study of hydrodynamic characteristics in human intestine applying residence time distribution analysis. Urtti Arto Ed. In Symposium on methods to overcome biological barriers in drug delivery. August 26-28, Kuopio University Publications A Pharm. Sci., 10:p73 (1993).
18. G. L. Amidon, J. Kou, R. L. Elliot, and E. N. Lightfood. Analysis of models for determining intestinal wall permeabilities. J. Pharm. Sci., 69:1369-73 (1980).
19. M. D. Levitt, J. M. Kneip, and D. G. Levitt. Use of laminar flow and unstirred layer models to predict intestinal absorption in the rat. J. Clin. Invest. 81:1365-9 (1988).
20. I. Komiya, J. Y. Park, A. Kamani, N. F. H. Ho, and W. I. Higuchi. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharmaceutics, 4,249-62 (1980).
21. P. J. Sinko, G. D. Leesman, and G. L. Amidon. Predicting fraction absorbed in humans using a macroscopic mass balance approach. Pharm. Res., 8:979-88 (1991).
22. G. L. Amidon, H. Lennernäs, V. Shah, and J. Crison. A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., 12:413-20 (1995).
23. R. D. Purves. MINIM 3.0. A Macintosh application for non-linear parameter estimation, 1994.
24. H. Yuasa, K. Matsuda, and J. Watanabe. Influence of anaesthetic regimens on intestinal absorption in rats. Pharm. Res., 10:884-8 (1993).
25. D. Winne, H. Görig, and U. Müller. Closed rat jejunal segment in situ: role of pre-epithelial diffusion resistance (unstirred layer) in the absorption process and model analysis. Naunyn-Schm. Arch Pharmacol., 335:204-15 (1987).
26. J. R. Pappenheimer and K. Z. Reiss. Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat. J. Membrane Biol., 100:123-36 (1987).
27. 2O and hydrophilic compounds in man and rat. Pharm. Res., 12:296 (1995).
28. Clarke's Isolation and Identification of Drugs, 2nd edition. Ed. A. C. Moffat. The Pharmaceutical Press, London, 1986.
29. Therapeutic Drugs. Ed. Sir C. Dollery. Churchill Livingstone, New York, 1991.
30. R. F. Rekker and R. Mannhold. In Calculation of Drug Lipophilicity. VCH Publishers, Weinheim, New York, Basel, Cambridge, 1992.
31. T. Itoh, R. Magavi, R. L. Casady, T. Nishihata, and J. H. Rytting. A method to predict percutaneous permeability of various compounds: Shed snake skin as a model membrane. Pharm. Res., 7:1302-6 (1990).
32. A. Sandberg. Extended-release metoprolol. Dissertation thesis, Uppsala, 1994.
33. P. Artursson and J. Karlsson. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Comm., 175:880-5 (1991).
34. Martindale, 27th edition. Ed. A. Wade, The Pharmaceutical Press, London, 1977.
35. G. Paintaud. Kinetics of drug absorption and influence of absorption rate on pharmacological effect. Dissertation thesis, Stockholm, 1993.